Status:
COMPLETED
Chewing Gum Containing Vitamin-c to Treat Emesis Gravidarum
Lead Sponsor:
Medical University of Vienna
Conditions:
Hyperemesis Gravidarum
Nausea Gravidarum
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Nausea and vomiting is a common complication of pregnancy and occurs in 70-80% of all pregnancies. The symptoms usually start 2-4 weeks after fertilization and peak between the 9th and 16th week of ge...
Detailed Description
The following 3 groups of patients should be compared: (1) patients with emesis gravidarum who take a chewing gum with vitamin C (verum) "ad libitum" several times daily for 2 weeks; (2.) patients wit...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- age ≥18 years
- singleton pregnancy
- signed information sheet
- symptoms of nausea and / or vomiting in early pregnancy
- no pre-existing medication for nausea and vomiting
- Exclusion criteria:
- age \<18 years
- multiple pregnancy
- patients with gastric band or in Z.n. bariatric surgery
- preexisting diabetes mellitus or gestational diabetes
- inability to consent to participation in the study
- already started therapy against the emesis gravidarum
- taking any antiemetic drugs during the study phase
Exclusion
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04284696
Start Date
February 11 2020
End Date
June 1 2022
Last Update
June 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna, Dept. of Obstetrics and Gynecology
Vienna, Austria, 1090